west virginia glp-1 pancreatitis lawsuit Lipsitz, Ponterio & Comerford |

not using GLP-1 receptor agonists had significantly lower relative risks for mortality and respiratory failure, according to a presentation at the CHEST Annual Meeting.In a retrospective study, Saud Alawad, MBBS, third-year internal medicine resident at West Virginia University, and colleagues analyzed adults with a group 1 PAH

Exec SummaryDanuglipron is an experimental weight loss medication being developed by Pfizer

Olubunmi Oladunjoye discusses GLP-1 medications for weight management, including their rise in popularity and possible side effects.

It requires a better patient experience

A balanced microbiome environment can help support pathways involved in energy metabolism and appetite regulation

Join over 5 million people who chose GOLO as a better way to lose weight.